Definitive Contract 75A50124C00048

Nytricx, Inc., a self-certified small disadvantaged business, was awarded a $745,973 firm-fixed-price contract by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response for research and development of an extracorporeal membrane oxygenation (ECMO) circuit with nitric oxide-releasing surface coatings. The contract, which was not set aside for any specific business type, aims to prevent thrombosis and infection in ECMO circuits. Nytricx, Inc. has previously received multiple federal grants from agencies such as the National Heart, Lung, and Blood Institute, Defense Health Agency, and National Institute of Diabetes and Digestive and Kidney Diseases for the development of advanced medical technologies, including antimicrobial wound dressings and nitric oxide-releasing intravascular catheters.